Rybrevant Faspro Wins Accelerated Approval for Advanced Head and Neck Cancer After 42% of Trial Patients Responded Medical Daily 12h
J&J’s Rybrevant Faspro Should See Few Challenges In Head And Neck Uptake Scrip Pharma Intelligence 1d
FDA expands J&J’s Rybrevant Faspro label with head and neck cancer approval Pharmaceutical Technology 1d
Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer PR Newswire (Press Release) 2d FDA
GI Innovation doses 1st patient in prostate cancer trial with J&J's pasritamig Korea Biomedical Review 3d Prostate Cancer Cancer Cancer Treatment
A $34 billion merger collapsed because two companies couldn't agree on one CEO Coinpaper 15:37 Mon, 26 Oct Pharma
US approval may speed HIV prevention in poor countries HumanProgress 4d HIV Pharma Global Health All sources
RFK Jr. Sidestepped the FDA on peptides access—why we're worried Allure 4d Robert F. Kennedy Jr HHS Pharma All sources
Zepto, Biryani By Kilo among 105 outlets face Mundhe crackdown before Diwali India Today 20h Hinduism Mumbai India All sources
Rs 63 crore of food seized in Maharashtra before Diwali: What to watch out for Indian Express 2d Hinduism India Mumbai All sources
ANI to expand its rare disease portfolio with Egetis takeout Scrip Pharma Intelligence 2d FDA Mergers and Acquisitions Rare Diseases
6 biotech stocks for a volatile bull market: Jon Erlichman BNN Bloomberg 2d Bull Market Biotechnology
CBI FIR against waste management company Hanjer Biotech for defrauding bank of $10 million under guise of setting up recycling plant in UK; 2nd fraud case The Times of India 1d Biotech Mumbai India
